Visalli, M A <br/><br/>
Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 1997 
 - 2786-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.41.12.2786  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Amoxicillin--pharmacology<br/>Ampicillin--pharmacology<br/>Anti-Bacterial Agents--pharmacology<br/>Anti-Infective Agents--pharmacology<br/>Aza Compounds<br/>Ceftizoxime--analogs & derivatives<br/>Cefuroxime--pharmacology<br/>Fluoroquinolones<br/>Microbial Sensitivity Tests<br/>Moxifloxacin<br/>Penicillin Resistance<br/>Quinolines<br/>Quinolones--pharmacology<br/>Streptococcus pneumoniae--drug effects<br/>Cefpodoxime